Home›Stock Screener›Shilpa Medicare›Quarterly Results

Shilpa Medicare Quarterly Results

Latest Quarter Net Profit
₹79 Cr
QSept 2026
Quarterly Results

Shilpa Medicare quarterly results. In Sept 2026, Shilpa Medicare (SHILPAMED) reported revenue ₹538 Cr and net profit ₹79 Cr — revenue +44.6% YoY. Also explore Shilpa Medicare stock price data download to track price trends across different timeframes.

SHILPAMED Quarterly Results — Revenue, Profit & EPS Highlights

Shilpa Medicare latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit SHILPAMED share price.

  • Revenue of ₹538 Cr in Sept 2026 (+11.6% vs Mar 2026, +44.6% vs Sept 2025)
  • Net Profit of ₹79 Cr in Sept 2026 (-26.9% vs Mar 2026, +79.5% vs Sept 2025)
  • EBITDA of ₹151 Cr in Sept 2026 (-8.5% vs Mar 2026)
  • Operating Margin of 27.0% in Sept 2026 (+0.0pp vs Mar 2026)
  • Earnings Per Share of ₹4.05 in Sept 2026 (-26.5% vs Mar 2026)

Shilpa Medicare Quarterly Results — Revenue, EBITDA, Net Profit & EPS

SHILPAMED quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 538 482 475 372 341 11.6% 44.6%
Net Profit (₹ Cr) 79 108 101 44 15 - -
EBITDA (₹ Cr) 151 165 145 110 59 - -
EPS (₹) 4.05 5.51 5.16 5.50 0.74 - -
Operating Margin (%) 27.0% 27.0% 29.0% 29.0% 15.0% - -

SHILPAMED Share Price Trend — 1-Year Movement Across Quarterly Results

Shilpa Medicare 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. View SHILPAMED 52-week chart for the annual high/low range and current price position.

Profitability Ratios

Profit Margin 14.7%
EBITDA Margin 28.1%
Operating Margin 27.0%
ROE (Annual) 12.2%

Balance Sheet Highlights

Total Assets ₹3,706 Cr
Total Equity ₹2,591 Cr
Current Assets ₹ Cr
Current Liabilities ₹266 Cr

Cash Flow Analysis

Operating Cash Flow ₹342 Cr
Investing Cash Flow ₹-339 Cr
Financing Cash Flow ₹14 Cr
Net Cash Flow ₹17 Cr

Current Market Data

Current Price ₹900.70
Exchange NSE
Last Updated Nov 19, 2026

SHILPAMED vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Shilpa Medicare latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores